Literature DB >> 26892779

Non-susceptibility of Escherichia coli, Klebsiella spp., Pseudomonas spp., Streptococcus pneumoniae and Staphylococcus aureus in the UK: temporal trends in England, Northern Ireland, Scotland and Wales.

Rebecca Guy1, Lourda Geoghegan2, Maggie Heginbothom3, Robin Howe4, Berit Muller-Pebody1, Jacqui S Reilly5, Julie Wilson5, Camilla Wiuff5, Tim Wyatt2, Alan P Johnson6.   

Abstract

OBJECTIVES: To monitor and compare trends in the non-susceptibility of bloodstream isolates of pathogens to key antibiotics in the constituent countries of the UK between 2010 and 2014.
METHODS: Routinely generated antibiotic susceptibility test results for bloodstream isolates of Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas spp., Streptococcus pneumoniae and Staphylococcus aureus were collected from hospital microbiology laboratories in each country.
RESULTS: With the exception of a decrease in the proportion of S. aureus that were MRSA, non-susceptibility to key antibiotics among the pathogens studied remained largely unchanged over the 5 year study period, with any increases in non-susceptibility being small. Although some intercountry variation in the proportions of non-susceptible isolates was seen, apart from MRSA, the differences were generally small (<5%) and fluctuated from year to year, with no country showing consistently higher or lower rates of resistance.
CONCLUSIONS: Collaboration between the constituent countries of the UK allows an integrated approach to nationwide surveillance of antibiotic resistance.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26892779     DOI: 10.1093/jac/dkw018

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

1.  The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.

Authors:  Jean-Winoc Decousser; Paul-Louis Woerther; Claude-James Soussy; Marguerite Fines-Guyon; Michael J Dowzicky
Journal:  Antimicrob Resist Infect Control       Date:  2018-05-30       Impact factor: 4.887

2.  Hospitalisations with infections related to antimicrobial-resistant bacteria from the French nationwide hospital discharge database, 2016.

Authors:  M Opatowski; P Tuppin; K Cosker; M Touat; G De Lagasnerie; D Guillemot; J Salomon; C Brun-Buisson; L Watier
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

3.  Improved penicillin susceptibility of Streptococcus pneumoniae and increased penicillin consumption in Japan, 2013-18.

Authors:  Shinya Tsuzuki; Takayuki Akiyama; Nobuaki Matsunaga; Koji Yahara; Keigo Shibayama; Motoyuki Sugai; Norio Ohmagari
Journal:  PLoS One       Date:  2020-10-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.